The nucleoside analogue D-carba T blocks HIV-1 reverse transcription

Paul L Boyer1, B Christie Vu, Zandrea Ambrose

  • 1HIV Drug Resistance Program, NCI-Frederick, Frederick, Maryland 21702, USA.

Insights

Novel nucleoside reverse transcriptase inhibitors (NRTIs) show promise against drug-resistant HIV-1. D-carba T, a carbocyclic nucleoside, effectively inhibits viral replication with no observed toxicity in cell cultures.

Area of Science:

  • Biochemistry
  • Virology
  • Medicinal Chemistry

Background:

  • HIV-1 resistance to nucleoside reverse transcriptase inhibitors (NRTIs) is a significant clinical challenge.
  • This resistance often arises from mutations in reverse transcriptase (RT) that promote NRTI excision via pyrophosphorolysis.
  • Developing NRTIs that overcome these resistance mechanisms is crucial for effective HIV-1 treatment.

Purpose of the Study:

  • To evaluate novel nucleoside analogs, specifically D-carba T, for their efficacy against HIV-1 RT mutants exhibiting excision proficiency.
  • To investigate the mechanism of action and potential therapeutic value of D-carba T in the context of NRTI resistance.

Main Methods:

  • Synthesis and characterization of D-carba T, a carbocyclic nucleoside analog.
  • Assessment of D-carba T's conversion to its active triphosphate form (D-carba T-TP) by host cell kinases.
  • Evaluation of HIV-1 RT's incorporation of D-carba T-TP and subsequent nucleotide addition kinetics.
  • Testing the antiviral activity of D-carba T against viral vectors utilizing NRTI-resistant HIV-1 RTs.
  • In vitro toxicity assessments in cultured cells.

Main Results:

  • D-carba T is efficiently converted to D-carba T-TP by host kinases.
  • HIV-1 RT readily incorporates D-carba T-TP, but subsequent dNTP addition to the primer terminus is significantly slowed.
  • D-carba T demonstrated effective inhibition of viral vectors harboring NRTI-resistant HIV-1 RTs.
  • No significant toxicity was observed in cultured cells treated with D-carba T.

Conclusions:

  • Carbocyclic nucleoside analogs like D-carba T represent a promising strategy for combating NRTI-resistant HIV-1.
  • The unique structure of D-carba T confers resistance to pyrophosphorolytic excision, a key resistance mechanism.
  • Further development of NRTIs based on the carbocyclic pseudosugar scaffold holds potential for improved HIV-1 treatment regimens.

Related Concept Videos

Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Retroviruses02:33

Retroviruses

Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...